RECCE PHARMACEUTICALS LTD — Capital/Financing Update 2019

Feb 5, 2019

Market Announcement

==> picture [33 x 50] intentionally omitted <==

6 February 2019

==> picture [451 x 5] intentionally omitted <==

Recce Pharmaceuticals Ltd (ASX: RCE) – Trading Halt

Description

The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be placed in trading halt at the request of RCE, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 8 February 2019 or when the announcement is released to the market.

Issued by

Madeleine Green

Adviser, Listings Compliance (Perth)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

6 February 2019 ASX Limited

==> picture [595 x 134] intentionally omitted <==

6 February 2019

Ms Anjuli Sinniah Senior Adviser, Listings Compliance (Perth) Level 40 Central Park 152 - 158 St George’s Terrace PERTH WA 6000

By email: tradinghaltsperth@asx.com.au

Dear Anjuli

Recce Pharmaceuticals Ltd (ASX:RCE) – Trading halt request

Pursuant to ASX Listing Rule 17.1, Recce Pharmaceuticals Ltd ACN 124 849 065 ( Company ) requests a trading halt of the Company’s securities pending the release of an announcement relating to a material capital raising. The capital raising will involve a placement to institutional investors.

The Company requests that the trading halt be effective immediately and remain in place until the earlier of the commencement of normal trading on Friday, 8 February 2019 or the release of an announcement by the Company in relation to the material capital raising.

The Company is not aware of any reason why the trading halt should not be granted.

For any questions, please contact the undersigned on +61 2 8072 1400.

Yours faithfully

==> picture [126 x 54] intentionally omitted <==

Alistair McKeough Company Secretary

==> picture [595 x 99] intentionally omitted <==